1. Home
  2. ALTO vs LAB Comparison

ALTO vs LAB Comparison

Compare ALTO & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ALTO

Alto Ingredients Inc.

HOLD

Current Price

$5.18

Market Cap

420.7M

Sector

Industrials

ML Signal

HOLD

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.86

Market Cap

347.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALTO
LAB
Founded
2003
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
420.7M
347.5M
IPO Year
2005
2008

Fundamental Metrics

Financial Performance
Metric
ALTO
LAB
Price
$5.18
$0.86
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$1.35
AVG Volume (30 Days)
2.6M
5.0M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
119.51
61.54
EPS
0.05
0.33
Revenue
$917,927,000.00
$101,937,000.00
Revenue This Year
$6.66
N/A
Revenue Next Year
$0.43
$2.63
P/E Ratio
$103.90
$2.56
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$0.70
52 Week High
$6.11
$1.72

Technical Indicators

Market Signals
Indicator
ALTO
LAB
Relative Strength Index (RSI) 44.56 47.94
Support Level $4.27 $0.79
Resistance Level $6.02 $1.02
Average True Range (ATR) 0.39 0.07
MACD -0.05 0.01
Stochastic Oscillator 19.83 60.45

Price Performance

Historical Comparison
ALTO
LAB

About ALTO Alto Ingredients Inc.

Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Share on Social Networks: